Table 3.
Number and Percentage of Types of Antibiotic Used for COVID-19 Patients (n = 120) Admitted to the Intensive Care Unit
| Use of Antibiotics | (%) |
|---|---|
| Azithromycin | |
| No | 23 (19.2) |
| Yes | 97 (80.8) |
| Imipenem | |
| No | 37 (30.8) |
| Yes | 83 (69.2) |
| Piperacillin/tazobactam | |
| No | 89 (74.2) |
| Yes | 31 (25.8) |
| Vancomycin | |
| No | 105 (87.5) |
| Yes | 15 (12.5) |
| Linezolid | |
| No | 85 (70.8) |
| Yes | 35 (29.2) |
| Fluoroquinolone | |
| No | 53 (44.2) |
| Yes | 67 (55.8) |
| Ceftriaxone | |
| No | 110 (91.7) |
| Yes | 10 (8.3) |
| Amikacin | |
| No | 114 (95.0) |
| Yes | 6 (5) |
| Amphotericin B | |
| No | 102 (87.9) |
| Yes | 14 (12.1) |